Corporate Travel (ASX: CTD) share price lifts on FY21 earnings

Here's how Corporate Travel performed through the financial year just been.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Corporate Travel Management Ltd (ASX: CTD) share price has lifted 0.21% this morning following the release of the ASX 200 travel solutions provider's financial year 2021 (FY21) results.

At the time of writing, the Corporate Travel share price is trading at $21.15.

A man sits in the airport terminal with a laptop and credit card, ready to make a travel booking.

Image source: Getty Images

Corporate Travel share price falls despite second half gains

Here's what Corporate Travel reported this morning:

The company advised that 48% of the company's FY21 income came from the Americas, 21% from Europe, 22% from Australia and New Zealand, and 9% from Asia.

Additionally, all of its operating regions earned a profit in the final quarter of FY21.

The company now believes its most exposed to regions with strong COVID-19 vaccination rates.

Corporate Travel finished the period with $99 million in cash and no debt

What happened in FY21 for Corporate Travel?

Here's the key news that drove the Corporate Travel share price in FY21.

In September, the company announced it acquired Travel & Transport. It did so after completing a $375 million capital raise.

The company states that its now a "significantly larger" business than it was before COVID-19 hit, mainly due to its major acquisition.

In fact, Corporate Travel's managing director Jamie Pherous said the it was estimated to be the fourth-largest global travel management company in the world.

What did management say?

Pherous commented on the earnings driving the company's share price today. He said:

We returned to positive underlying EBITDA in the second half because of a rapid turnaround in fourth quarter activity from North America and Europe. Significant progress in administering vaccines and reopening the economy in these regions gives us reason to be optimistic about FY22.

July has delivered a record revenue result post-COVID. The integration of Travel & Transport is progressing well and has helped us to capitalise on the momentum in North America and grow our exposure to the world's largest travel market.

What's next for Corporate Travel?

Corporate Travel hasn't given guidance for FY22. It stated the uncertainty of government decisions made in reaction to COVID-19 disallowed it to estimate its future earnings.

However, here's what might drive the Corporate Travel share price in the current financial year:

The company expects its underlying EBITDA to grow in the first quarter, though it noted quarter one is generally its softest. It also expects its growth will continue through the first half, as Transatlantic and intra-Europe travel is expected to open.

Finally, Corporate Travel hopes vaccinations will allow for a predictable and sustainably strong Australian domestic environment in the second half of FY22.

The company is again looking at unnamed acquisition opportunities.

Corporate Travel share price snapshot

The Corporate Travel share price has gained 23% year to date. It has also increased almost 79% since this time last year.

At the time of writing, the company has a market capitalisation of $2.9 billion.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

Doctor doing a telemedicine using laptop at a medical clinic
Earnings Results

Guess which ASX 200 stock is jumping 9% on FY26 results

This medical device company has released its FY 2026 results. Let's see what it reported.

Read more »

A man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.
Earnings Results

Webjet shares crash 15% as Virgin Australia blow hits outlook

Webjet shares are under heavy pressure after its latest update.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Earnings Results

James Hardie shares tumble on FY26 profit crunch

Investors have been hitting the sell button on Wednesday. Let's find out why.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Earnings Results

Why are Catapult Sport shares jumping 18% today?

This sports technology company has delivered a stronger than expected FY 2026 result.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Which ASX 200 share is crashing 22% on half-year results?

Let's see why investors are hitting the sell button on Monday.

Read more »

A man in a suit looks surprised as he looks through binoculars.
Earnings Results

Guess which ASX 200 stock is dropping despite record quarterly profit

It was a record-breaking quarter for this company.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Earnings Results

Why Xero shares are falling despite a big jump in revenue

Xero shares are under pressure as Melio costs weigh on profit.

Read more »

A man looking at his laptop and thinking.
Earnings Results

ASX 200 stock crashes 12% on half-year results

Profit is down but its guidance has been reaffirmed.

Read more »